Literature DB >> 8152586

Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia.

T Liu1, P R Young, P C McDonnell, R F White, F C Barone, G Z Feuerstein.   

Abstract

Cytokine-induced neutrophil chemoattractant (CINC), originally identified as a chemoattractant in rat kidney epithelial cells, is related to human 'gro' and murine 'KC'. The proteins encoded by these genes belong to the chemokine alpha superfamily, most of which have neutrophil chemotactic activity. Since brain chemokines may play a significant role in neutrophil accumulation in cerebral ischemia which can contribute to the extent of tissue injury in stroke, we examined the expression of CINC mRNA in the cerebral cortex of rats subjected to focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO). Significant CINC mRNA expression was observed in the ipsilateral (ischemic) cortex from 6 h (17.3 +/- 3.7%, n = 6, P < 0.05) to 24 h (32.1 +/- 3.7%, n = 5, P < 0.01) with a peak at 12 h (43.9 +/- 3.7%, n = 6, P < 0.01) after MCAO. Five days post-MCAO, CINC mRNA levels were no longer elevated. No significant CINC mRNA expression was observed in the contralateral (control) cortex. These studies suggest that message for the neutrophil chemoattractant CINC is induced early in brain tissue subjected to ischemia, and therefore supports the possibility that brain-derived chemokines support the infiltration of circulating inflammatory cells following focal stroke.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8152586     DOI: 10.1016/0304-3940(93)90873-j

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  Role of chemokines in ischemic neuronal stress.

Authors:  Masabumi Minami; Masamichi Satoh
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  Brain cytokines as neuromodulators in cardiovascular control.

Authors:  Peng Shi; Mohan K Raizada; Colin Sumners
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

4.  The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation.

Authors:  S Robinson; M Tani; R M Strieter; R M Ransohoff; R H Miller
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

5.  C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system.

Authors:  V C Asensio; S Lassmann; A Pagenstecher; S C Steffensen; S J Henriksen; I L Campbell
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

6.  Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes.

Authors:  M Tani; M E Fuentes; J W Peterson; B D Trapp; S K Durham; J K Loy; R Bravo; R M Ransohoff; S A Lira
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

Authors:  T L Sørensen; M Tani; J Jensen; V Pierce; C Lucchinetti; V A Folcik; S Qin; J Rottman; F Sellebjerg; R M Strieter; J L Frederiksen; R M Ransohoff
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.

Authors:  A E Kerstetter; D A Padovani-Claudio; L Bai; R H Miller
Journal:  Exp Neurol       Date:  2009-07-17       Impact factor: 5.330

9.  Curcuminoids limit neutrophil-mediated reperfusion injury in experimental stroke by targeting the endothelium.

Authors:  Janet L Funk; Jennifer B Frye; Grace Davis-Gorman; Allison L Spera; Michael J Bernas; Marlys H Witte; Martin E Weinand; Barbaba N Timmermann; Paul F McDonagh; Leslie Ritter
Journal:  Microcirculation       Date:  2013-08       Impact factor: 2.628

10.  Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.

Authors:  Pernille M Madsen; Bettina H Clausen; Matilda Degn; Stine Thyssen; Lotte K Kristensen; Martina Svensson; Nicholas Ditzel; Bente Finsen; Tomas Deierborg; Roberta Brambilla; Kate L Lambertsen
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.